ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $778,000 | -18.6% | 37,401 | -18.6% | 0.02% | -28.6% |
Q4 2016 | $956,000 | +37.2% | 45,971 | +116.1% | 0.02% | +50.0% |
Q3 2016 | $697,000 | +31.3% | 21,272 | +0.1% | 0.01% | 0.0% |
Q2 2016 | $531,000 | -37.6% | 21,254 | -38.8% | 0.01% | -39.1% |
Q1 2016 | $851,000 | -26.3% | 34,732 | -0.7% | 0.02% | -39.5% |
Q4 2015 | $1,155,000 | -34.2% | 34,982 | -34.7% | 0.04% | -47.2% |
Q3 2015 | $1,754,000 | -7.7% | 53,534 | +49.2% | 0.07% | +18.0% |
Q2 2015 | $1,900,000 | +162.4% | 35,875 | +42.9% | 0.06% | +144.0% |
Q1 2015 | $724,000 | – | 25,100 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |